Related Experiment Video

Updated: May 22, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Statins impair glucose uptake in tumor cells

Agata Malenda1, Anna Skrobanska, Tadeusz Issat

  • 1Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, Warsaw, Poland.

Neoplasia (New York, N.Y.)
|May 12, 2012
PubMed

Insights

Statins significantly reduce glucose uptake in tumor cells by affecting glucose transporter 1 (GLUT1) function, not expression. This finding impacts cancer diagnostics like positron emission tomography (PET) scans.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Statins are lipid-lowering drugs impacting cardiovascular health.
  • Statins modulate membrane cholesterol, influencing protein conformation, such as CD20.
  • The effect of statins on glucose metabolism in cancer cells is not well understood.

Purpose of the Study:

  • To investigate the impact of statins on glucose transporter 1 (GLUT1)-mediated glucose uptake in tumor cells.
  • To explore the clinical relevance of statins' effects on glucose uptake.

Main Methods:

  • In vitro studies using tumor cell lines to measure glucose analog uptake with statin treatment.
  • Reversibility assays using mevalonic acid and exogenous cholesterol.
  • Analysis of GLUT1 expression at transcriptional and protein levels.
  • Exploratory clinical trial in a mantle cell lymphoma patient.
  • Bioinformatics analysis of GLUT1 structure and cholesterol-binding motifs.

Main Results:

  • Statins caused a concentration- and time-dependent decrease in glucose uptake in tumor cells.
  • The effect was reversible upon restoring cholesterol synthesis or adding exogenous cholesterol.
  • Statins did not alter GLUT1 expression levels.
  • Clinical data showed reduced leukocyte and tumor (18)F-FDG uptake in a patient on statins.
  • Bioinformatics identified potential cholesterol-binding sites in GLUT1.

Conclusions:

  • Statins inhibit GLUT1-mediated glucose uptake in tumor cells through a mechanism independent of GLUT1 expression, likely involving cholesterol modulation.
  • Statin-induced reduction in (18)F-FDG uptake may compromise the sensitivity of PET scans used in oncology.
  • Further research is warranted to understand the clinical implications of statins on cancer imaging and metabolism.

More Related Videos

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...